Program details on keynote addresses, distinguished awards and late-breaking abstracts are being provided by program planners of the American Society for Radiation Oncology (ASTRO) Annual Meeting, set for October 23-26, in San Antonio, TX. Photo credit: Getty Images.
October 6, 2022 ‑— Ahead of the 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO), set for October 23-26, in San Antonio, TX, additional details on keynote addresses, distinguished awards and late-breaking abstracts are being provided by program planners.
Keynote Speakers Shine Spotlight on AI & EI
According to pre-event information from ASTRO on its 2022 Annual Meeting, an outstanding line-up of speakers and topics has been announced, including two dynamic keynote speakers focused on the meeting theme of AI & EI: Caring for the Patient in a Wireless World, in an effort to inform the bigger picture of the rapidly changing health care environment beyond radiation oncology.
Ruha Benjamin, PhD, professor, Department of African American Studies, Director of Graduate Affairs at Princeton University, will present a keynote address on Monday, Oct. 24 at 9:15 a.m. Dr. Benjamin’s specialty is in the interdisciplinary study of science, medicine and technology, race-ethnicity and gender, as well as knowledge and power. In “Race to the Future? Reimagining the Default Settings of Technology & Society,” she will discuss themes outlined in her book, Race After Technology, and include the social dimensions of data science, discriminatory design in technology, and how digital tools can replicate existing hierarchies and propagate racist policies. She has authored multiple books, book chapters and articles.
Richard Deming, MD, serves as Medical Director at MercyOne Des Moines Cancer Center. He is a radiation oncology specialist with over 41 years of experience, and founder of Above and Beyond Cancer Foundation. In his keynote address on Tuesday, Oct. 25 at 9:15 a.m., he will share his and his patients’ experience with the foundation, which takes cancer survivors and their families on international adventures to places like the Mount Everest Base Camp at the top of Mount Kilamanjaro.
“Gold Medal” and Inaugural “ASTRO Mentorship” Awards
The 2022 ASTRO Gold Medalists have been announced, and will be honored during the Oct. 25 Annual Meeting Awards Ceremony. The Gold Medalists are: Tim R. Williams, MD, FASTRO; and Wendell Lutz, PhD. Dr. Williams is the Medical Director at South Florida Proton Therapy Institute, and a former ASTRO president and chair. Lutz is a medical physicist who is known for his pioneering effort in the development of a linac-based stereotactic radiosurgery system, as well as other devices which have been adopted worldwide for quality assurance in radiation therapy.
Two members of ASTRO have been selected to receive its inaugural ASTRO Mentorship Award. According to the pre-event summary, this award recognizes extraordinary role models in radiation oncology who have excelled as mentors by demonstrating outstanding commitment to the professional development of their mentees as clinicians, educators and researchers. ASTRO will recognize the two recipients of that award at the Awards Ceremony on October 25. They are: Reshma Jagsi, MD, DPhil, FASTRO, University of Michigan in Ann Arbor, MI; and Charles Thomas Jr., MD, FASTRO, Geisel School of Medicine at Dartmouth, in Lebanon, New Hampshire.
Late-Breaking Abstracts
In addition to the poster presentations and large number of presentations, the following Special Scientific Sessions will be presented on Tuesday, Oct. 25, at 2:30 p.m. in the Hemisfair Ballroom/C2/C3 of the Henry B. Gonzalez Convention Center. ASTRO has also gathered brief, informative presenter videos, available on the website, offering insights into the topics scheduled throughout the Annual Meeting.
Moderators: Beth M Beadle MD, PhD, Stanford University; and Thomas J. Dilling MD, FASTRO, Moffitt Cancer Center
2:30 p.m.
“GETUG-AFU 22 Phase II Randomized Trial Evaluating Outcomes of Post-Operative Immediate Salvage Radiation Therapy with or without ADT for Patients with Persistently Elevated PSA Level”
Presenting Author: Igor Latorzeff, MD, Groupe ONCORAD Garonne
2:40 p.m.
“Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter, randomized phase II trial”
Presenting Author: Chad Tang MD, MD Anderson Cancer Center
2:50 p.m.
“Celiac Plexus Radio-Surgery for Pain Management in Advanced Cancer: An International Phase II Trial”
Presenting Author: Yaacov Lawrence MD, MRCP, Sheba Medical Center
3:00 p.m.
“Stereotactic MR-Guided On-Table Adaptive Radiation Therapy (SMART) for Patients with Borderline or Locally Advanced Pancreatic Cancer: Primary Endpoint Outcomes of a Prospective Phase II Multi-Center International Trial”
Presenting Author: Parag Jitendra Parikh MD, BSE, Henry Ford Hospital
3:10 p.m.
“Final Analysis of Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression Trial - A Randomized Study of Stereotactic Body Radiotherapy for Oligoprogressive Metastatic Lung and Breast Cancers”
Presenting Author: C Jillian Tsai MD, PhD, MS, Director, Metastatic Disease Radiation Oncology Research, Memorial Sloan Kettering Cancer Center
3:20 p.m.
“LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC)”
Presenting Author: Anand Swaminath MD, Juravinski Cancer Centre
3:30 p.m.
“Patterns of Failure After Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial”
Presenting Author: William Breen MD, Mayo Clinic Rochester
About ASTRO
The American Society for Radiation Oncology (ASTRO) is the largest radiation oncology society in the world, with nearly 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies.
ASTRO is led by Board Chair Laura A. Dawson, MD, Princess Margaret Cancer Centre, Toronto, Ontario. Dawson is an active radiation oncologist and the upper gastrointestinal cancer multi-disciplinary site lead at the Princess Margaret Cancer Centre, and Professor of Radiation Oncology at the University of Toronto. She leads the palliative radiation oncology program (PROP) and treats patients with gastrointestinal malignancies and patients with oligo-metastases from a variety of malignancies.
ASTRO 2022 Chair Geraldine Jacobson, MD is the founding Chair and a professor of radiation oncology at West Virginia University, as well as the Physician in Chief for Radiation Oncology for the West Virginia University Hospital System.
For additional information: https://www.astro.org/Meetings-and-Education/Micro-Sites/2022/Annual-Meeting
Related Content:
https://www.itnonline.com/content/astro-2022-set-san-antonio-focus-ai-and-ei
April 25, 2024 
